Author Correction: An oncogenic Ezh2 mutation induces tumors through global redistribution of histone 3 lysine 27 trimethylation.

Saved in:
Bibliographic Details
Title: Author Correction: An oncogenic Ezh2 mutation induces tumors through global redistribution of histone 3 lysine 27 trimethylation.
Authors: Souroullas GP; Department of Genetics, University of North Carolina (UNC) School of Medicine, Chapel Hill, North Carolina, USA.; Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA., Jeck WR; Department of Genetics, University of North Carolina (UNC) School of Medicine, Chapel Hill, North Carolina, USA.; Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA., Parker JS; Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA., Simon JM; Department of Genetics, University of North Carolina (UNC) School of Medicine, Chapel Hill, North Carolina, USA.; Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA., Liu JY; Department of Genetics, University of North Carolina (UNC) School of Medicine, Chapel Hill, North Carolina, USA.; Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA., Paulk J; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA., Xiong J; Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA., Clark KS; Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA., Fedoriw Y; Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.; Department of Pathology and Laboratory Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA., Qi J; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA., Burd CE; Department of Molecular Genetics, Ohio State University, Columbus, Ohio, USA.; Department of Molecular Virology, Immunology and Medical Genetics, Ohio State University, Columbus, Ohio, USA., Bradner JE; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Sharpless NE; Department of Genetics, University of North Carolina (UNC) School of Medicine, Chapel Hill, North Carolina, USA. nes@med.unc.edu.; Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA. nes@med.unc.edu.; Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA. nes@med.unc.edu.
Source: Nature medicine [Nat Med] 2024 Jun; Vol. 30 (6), pp. 1784.
Publication Type: Published Erratum
Journal Info: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE; PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1546-170X
DOI:10.1038/s41591-024-02867-1